Nikolaos Galanakis: Percutaneous Mechanical Thrombectomy has Emerged as a Valuable Treatment Option in Acute Limb Ischemia
Nikolaos Galanakis, Assistant Professor of Interventional Radiology Medical School / University of Crete, shared a post on LinkedIn:
“IRchalenge day 4…
Percutaneous mechanical thrombectomy (PMT) has emerged as a valuable treatment option in acute limb ischemia (ALI), offering rapid restoration of arterial flow while minimizing the risks associated with open surgery or prolonged thrombolysis. By mechanically fragmenting and removing thrombotic material, PMT provides rapid reperfusion, a key determinant for limb salvage and prevention of ischemic complications.
A 67-year-old male presented with ALI due to acute thrombosis of a femoropopliteal bypass graft, originally created for treatment of a popliteal artery aneurysm. The patient underwent percutaneous pharmacomechanical thrombectomy using the AngioJet device and angioplasty, achieving significant restoration of arterial flow.
This is the power of IR. Keep the momentum going at CIRSE2025!”
Find more on Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies